Functional characterization of common protein variants in the efflux transporter ABCC11 and identification of T546M as functionally damaging variant

被引:0
作者
R Arlanov
T Lang
G Jedlitschky
E Schaeffeler
T Ishikawa
M Schwab
A T Nies
机构
[1] Dr Margarete Fischer-Bosch Institute of Clinical Pharmacology,Department of Pharmacology
[2] Stuttgart and University of Tübingen,Department of Clinical Pharmacology
[3] Stuttgart,undefined
[4] Germany,undefined
[5] Center of Drug Absorption and Transport (C_DAT),undefined
[6] University Medicine of Greifswald,undefined
[7] RIKEN Center for Life Science Technologies,undefined
[8] Institute of Experimental and Clinical Pharmacology and Toxicology,undefined
[9] University Hospital of Tübingen,undefined
来源
The Pharmacogenomics Journal | 2016年 / 16卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Multidrug resistance protein 8 (ABCC11) is an efflux transporter for anionic lipophilic compounds, conferring resistance to antiviral and anticancer agents like 5-fluorouracil (5-FU). ABCC11 missense variants may contribute to variability in drug response but functional consequences, except for the ‘earwax variant’ c.538G>A, are unknown. Using the ‘Screen and Insert’ technology, we generated human embryonic kidney 293 cells stably expressing ABCC11 missense variants frequently occurring in different ethnic populations: c.57G>A, c.538G>A, c.950C>A, c.1637C>T, c.1942G>A, c.4032A>G. A series of in silico prediction analyses and in vitro plasma membrane vesicle uptake, immunoblotting and immunolocalization experiments were undertaken to investigate functional consequences. We identified c.1637C>T (T546M), previously associated with 5-FU-related toxicity, as a novel functionally damaging ABCC11 variant exhibiting markedly reduced transport function of 5-FdUMP, the active cytotoxic metabolite of 5-FU. Detailed analysis of 14 subpopulations revealed highest allele frequencies of c.1637C>T in Europeans and Americans (up to 11%) compared with Africans and Asians (up to 3%).
引用
收藏
页码:193 / 201
页数:8
相关论文
共 162 条
  • [21] Guo Y(2012)Functional characterization of protein variants of the human multidrug transporter ABCC2 by a novel targeted expression system in fibrosarcoma cells Hum Mutat 33 750-616
  • [22] Kotova E(1998)Transport function and substrate specificity of multidrug resistance protein Methods Enzymol 292 607-1328
  • [23] Chen ZS(2000)Impaired protein maturation of the conjugate export pump multidrug resistance protein 2 as a consequence of a deletion mutation in Dubin-Johnson syndrome Hepatology 32 1317-487
  • [24] Lee K(2014)A comprehensive functional and clinical analysis of ABCC2 and its impact on treatment response to carbamazepine Pharmacogenomics J 14 481-567
  • [25] Hopper-Borge E(2007)Structure and function of ABC transporters: the ATP switch provides flexible control Pflugers Arch 453 555-4858
  • [26] Belinsky MG(1992)Expression of the human multidrug resistance cDNA in insect cells generates a high activity drug-stimulated membrane ATPase J Biol Chem 267 4854-8
  • [27] Toyoda Y(2012)Rare versus common variants in pharmacogenetics: SLCO1B1 variation and methotrexate disposition Genome Res 22 1-243
  • [28] Ishikawa T(2013)Genetics is a major determinant of expression of the human hepatic uptake transporter OATP1B1, but not of OATP1B3 and OATP2B1 Genome Med 5 1-9249
  • [29] Chen ZS(2015)Role of ABC transporters in fluoropyrimidine-based chemotherapy response Adv Cancer Res 125 217-13108
  • [30] Guo Y(2003)The human multidrug resistance protein MRP4 functions as a prostaglandin efflux transporter and is inhibited by nonsteroidal antiinflammatory drugs Proc Natl Acad Sci USA 100 9244-734